Biomarker Market
Biomarker Market Study by Cardiovascular Diseases, Cancer, Neurological Diseases, and Immunological Diseases for Safety, Efficacy, and Validation from 2024 to 2034
Analysis of Biomarker Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Biomarkers Market Outlook (2024 to 2034)
Revenue from the sales of biomarkers is expected to reach US$ 74.92 billion in 2024, as revealed in the updated market report published by Fact.MR. The global biomarkers market size is approximated to expand at a double-digit CAGR of 15% and reach a value of US$ 303.98 billion by the end of 2034.
In the recent past, there has been an increase in cases of fatal diseases, including cardiovascular disorders, diabetes, and cancer. One of the primary factors responsible for this is lifestyle changes. The use of biomarkers for the diagnosis of infectious and chronic diseases has become more common.
For instance :
- In 2020, Frontiers mentioned some potential MicroRNA-based biomarkers, which were identified for the diagnosis of infectious diseases, including Ebola, influenza infections, HIV, rhinoviruses, malaria, tuberculosis, and Hendra virus. They aimed to facilitate early diagnosis of infectious diseases.
Innovative treatments combining biomarkers with existing or new medicines are being launched in the healthcare sector. Biomarkers are utilized for the treatment of neurological diseases for tracking brain health while measuring molecules. It has become easier to develop neurological treatment solutions with these biomarkers, facilitated by faster drug development, early diagnosis, and noninvasive testing.
The emergence of digital biomarkers has assisted pharmaceutical companies with supplementary and contextual information for making decisions during clinical trials. In addition, they play a pivotal role in selecting targeted therapies addressing the molecular characteristics of tumors.
- Worldwide demand for biomarkers for use in cancer treatment is evaluated to accelerate at a CAGR of 15.4% and reach a value of US$ 116.52 billion by the end of 2034.
- North America is forecasted to account for 35.2% of the global biomarker market share by 2034-end.
- Sales of biomarkers in China are projected to climb at 19.6% CAGR and reach US$ 33.78 billion by 2034.
| Report Attribute | Detail |
|---|---|
| Biomarker Market Size (2024E) | US$ 74.92 Billion |
| Forecasted Market Value (2034F) | US$ 303.98 Billion |
| Global Market Growth Rate (2024 to 2034) | 15% CAGR |
| Market Share of Safety Biomarkers (2034F) | 36.5% |
| South Asia & Pacific Market Share (2034F) | 21.8% |
| South Korea Market Growth Rate (2024 to 2034) | 17% CAGR |
| Key Companies Profiled | Agilent Technologies, Inc.; Qiagen; Abbot Laboratories; F. Hoffman-La Roche Ltd.; Merck KGaA; Siemens Healthineers AG; Epigenetics AG; Bio-Rad Laboratories Inc.; General Electric; Thermo Fisher Scientific Inc.; PerkinElmer Inc.; Johnson & Johnson Services Inc. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What Factors are Audibly Promulgating Biomarker Demand?
“Growing Use of Biomarkers in Diagnostics”
Compared to conventional diagnostic tools, modern diagnostic equipment ensures early, consistent, and accurate results. Biomarkers are being integrated with modern key imaging and advanced data management technologies. Further, these tools assist in early disease detection. Medical practices need an accurate diagnosis of conditions and illnesses. Diagnostic biomarkers determine if a patient with a particular medical condition requires specific treatment or must be enrolled for clinical trial investigation.
It has been recognized that various diseases with subtypes have different responses or prognoses to a specific treatment. There has been an increase in the use of diagnostic biomarkers in symptomatic patients compared to screening biomarkers.
“Increasing Cases of Cancer Contributing to Growing Demand for Biomarkers”
In recent years, there has been a significant increase in cancer cases. Cancer is becoming one of the prominent reasons for death globally, according to the World Health Organization. Increasing cancer cases are owing to poor dietary habits, lazy lifestyles, and smoking. Biomarkers are used to provide information about this disease. There are some unique patterns associated with each patient’s cancer, which affect the treatment process. They are utilized for monitoring disease development and risk assessment with the assistance of biomarkers.
Which Key Challenges are Prevalent in the Global Market?
“Expensive and Time-consuming R&D Procedures for Biomarker Medicines”
Huge capital is required for biomarkers, which has been affecting R&D activities related to the diagnosis and development of medicines. In addition, biomarker validation is a time-consuming procedure, which adversely impacts the productivity of market players.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Biomarker Market Trends are Paving the Way for Startups?
“Growing Investments in Identifying Disease Preventing Biomarkers”
Some areas of interest for startups in the global market include biomarker pharmaceuticals, biomarker strategies, and biomarker science. Among these, biomarker science is becoming more popular. It is engaged in identifying disease prevention biomarkers using proteomics and genomics technology. Cartilage degeneration markers, exercise and oxidation stress markers, and preventive medicines are some discovered biomarkers. New market players are offering services in planning clinical trials of functional materials and functional foods.
Country-wise Insights
North America is forecasted to hold a 35.2% share of the global market by the end of 2034, as stated in the research report prepared by skilled analysts at Fact.MR, a market research and competitive intelligence provider. Increased disease burden and improvements in healthcare infrastructure are contributing to increased demand for biomarkers. Moreover, the presence of key providers in the region, such as Merck & Co., Bio-Rad Laboratories, Inc., Abbot, and Thermo Fisher Scientific, is also contributing to biomarker market growth.
Why is the United States Exhibiting a Higher Demand for Biomarkers?
“Rapidly Increasing Cases of Chronic Diseases in the Country”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 23.09 Billion |
| Growth Rate (2024 to 2034) | 16.5% CAGR |
| Projected Value (2034F) | US$ 106.44 Billion |
The United States is analyzed to capture a share of 80.7% of the market in North America by 2034-end. In the past few years, there has been an increase in the number of U.S. FDA-approved drugs containing molecular biomarkers. These biomarkers are identified and validated for developing drugs and assisting in drug approval. Rapidly rising cases of chronic diseases and an increase in drug development and approvals are complementing biomarker market size expansion in the United States.
What Makes India a Key Market for Biomarker Suppliers?
“Increasing Investments in R&D Activities for Drug Development”
| Attribute | India |
|---|---|
| Market Value (2024E) | US$ 3.82 Billion |
| Growth Rate (2024 to 2034) | 22.6% CAGR |
| Projected Value (2034F) | US$ 29.38 Billion |
India is evaluated to occupy 71.4% of the South Asia & Pacific market share by the end of 2034. Flourishing pharmaceutical industry in the country is leading to increased investments in R&D activities using biomarkers for drug development. Supportive policies and programs for outpatient and in-patient procedures for disease diagnosis is also contributing to the rising demand for biomarkers.
What are the Growth Driving Factors for the South Korean Market?
“Surging Use of Biomarkers in Personalized Medicine”
| Attribute | South Korea |
|---|---|
| Market Value (2024E) | US$ 3.11 Billion |
| Growth Rate (2024 to 2034) | 17% CAGR |
| Projected Value (2034F) | US$ 15 Billion |
South Korea is forecasted to account for 26.7% of the East Asian market share by 2034-end. Biomarkers are significantly used in developing personalized medicine in the country. In addition, revenue in the market is being increased with the growing use of biomarkers in disease development for further use in cancer diagnosis.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Worldwide demand for biomarkers for drug discovery and development applications is projected to accelerate at a CAGR of 15.3% and reach a value of US$ 108.59 billion by the end of 2034. They play a crucial role in medical practice and drug development by offering information about patient status in clinical settings. Biomarkers provide information about pharmacodynamic activity, efficacy, and safety throughout drug development.
Which Type Biomarker Accounts for High Revenue Generation?
“Increasing Application of Safety Biomarkers for Neurological Disease Treatment”
| Attribute | Safety |
|---|---|
| Segment Value (2024E) | US$ 26.91 Billion |
| Growth Rate (2024 to 2034) | 15.2% CAGR |
| Projected Value (2034F) | US$ 110.81 Billion |
Safety biomarkers are calculated to account for 36.5% share of the global market by the end of 2034. In recent years, there has been a noteworthy increase in the use of safety biomarkers for treating neurological diseases. In addition, biomarkers are also used for the treatment of various other diseases such as kidney disorders and cardiovascular diseases. Moreover, rising awareness about regular health checkups and the risk of developing certain diseases such as cardiovascular diseases and cancer are contributing to the increased demand for biomarkers.
For Which Disease is Biomarkers Significantly Used?
“High Popularity of Biomarkers for Cancer Detection and Treatment”
| Attribute | Cancer |
|---|---|
| Segment Value (2024E) | US$ 27.88 Billion |
| Growth Rate (2024 to 2034) | 15.4% CAGR |
| Projected Value (2034F) | US$ 116.52 Billion |
Biomarkers for use in cancer treatment are calculated to contribute a share of 38.3% of global market revenue by 2034. Increasing use of biomarkers for prognosis and monitoring treatment against cancer is driving their demand in the healthcare industry. Multiple methods, such as non-invasive and invasive, are used for cancer detection through biomarkers. They are used as pivotal biological molecules for cancer detection at different stages, thereby helping in treatment procedures.
Competitive Landscape
Key players in the biomarker market are actively working to identify new application areas and thereby are investing in R&D activities. Agreements, partnerships, acquisition, and new product development are some of the strategies helping market players gain a competitive edge. In addition, offering quality products and effectively managing the supply chain system also assist market players to secure and expand their footprints.
For instance :
- F. Hoffman La Roche Ltd., in April 2021, launched two new cardiac biomarker tests, the NTproBNP (N-Terminal Pro Brain Natriuretic Peptide) and cTnThs (Sensitive Cardiac Troponin) Test. These standard biomarkers support managing cardiovascular diseases, helping physicians diagnose heart functioning and efficiently manage any failure.
- Thermo Fisher Scientific, in July 2020, entered into an agreement with Chugai to expand the application of Oncomine Dx target tests. The companies are planning to use these tests with NSCLC (non-small cell lung cancer) and accelerate the area of local biomarker tests.
Fact.MR provides detailed information about the price points of key manufacturers of biomarkers positioned across the world, sales growth, production capacity, and speculative technological expansion, in the recently updated market report.
Segmentation of Biomarker Market Research
-
By Disease :
- Cardiovascular Diseases
- Cancer
- Neurological Diseases
- Immunological Diseases
- Other Disease Types
-
By Type :
- Safety
- Efficacy
- Validation
-
By Application :
- Diagnostics
- Drug Discovery & Development
- Personalized Medicines
- Other Applications
-
By Region :
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia & Pacific
- MEA
Table of Content
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. Disease 6.2. Type 6.3. Application 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Disease 7.1. Cardiovascular Diseases 7.2. Cancer 7.3. Neurological Diseases 7.4. Immunological Diseases 7.5. Other Disease Types 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Type 8.1. Safety 8.2. Efficacy 8.3. Validation 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Application 9.1. Diagnostics 9.2. Drug Discovery & Development 9.3. Personalized Medicines 9.4. Other Applications 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. Eastern Europe 10.5. East Asia 10.6. South Asia & Pacific 10.7. Middle East & Africa 11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. Sales Forecast 2024 to 2034 by Disease, Type, Application, and Region for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. Agilent Technologies, Inc. 20.2. Qiagen 20.3. Abbot Laboratories 20.4. F. Hoffman-La Roche Ltd. 20.5. Merck KGaA 20.6. Siemens Healthineers AG 20.7. Epigenetics AG 20.8. Bio-Rad Laboratories Inc. 20.9. General Electric 20.10. Thermo Fisher Scientific Inc. 20.11. PerkinElmer Inc. 20.12. Johnson & Johnson Services Inc. 21. Assumptions and Acronyms Diseased 22. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Type, 2019 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Type, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Type, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Type, 2019 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Type, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Type, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 28: Latin America Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 29: Latin America Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Type, 2019 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Type, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Type, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 37: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 38: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Western Europe Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 41: Western Europe Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 42: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 43: Western Europe Market Value (US$ Mn) Analysis, by Type, 2019 to 2023
Table 44: Western Europe Market Value (US$ Mn) Analysis, by Type, 2024 to 2034
Table 45: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Type, 2024 to 2034
Table 46: Western Europe Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 47: Western Europe Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 48: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 49: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 50: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 51: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 52: Eastern Europe Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 53: Eastern Europe Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 54: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 55: Eastern Europe Market Value (US$ Mn) Analysis, by Type, 2019 to 2023
Table 56: Eastern Europe Market Value (US$ Mn) Analysis, by Type, 2024 to 2034
Table 57: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Type, 2024 to 2034
Table 58: Eastern Europe Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 59: Eastern Europe Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 60: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 61: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 62: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: East Asia Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 65: East Asia Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 66: East Asia Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 67: East Asia Market Value (US$ Mn) Analysis, by Type, 2019 to 2023
Table 68: East Asia Market Value (US$ Mn) Analysis, by Type, 2024 to 2034
Table 69: East Asia Market Value (US$ Mn) Opportunity Analysis, by Type, 2024 to 2034
Table 70: East Asia Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 71: East Asia Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 72: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 73: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 74: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: South Asia & Pacific Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 77: South Asia & Pacific Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 78: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 79: South Asia & Pacific Market Value (US$ Mn) Analysis, by Type, 2019 to 2023
Table 80: South Asia & Pacific Market Value (US$ Mn) Analysis, by Type, 2024 to 2034
Table 81: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Type, 2024 to 2034
Table 82: South Asia & Pacific Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 83: South Asia & Pacific Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 84: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 85: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 86: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 87: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 88: MEA Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 89: MEA Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 90: MEA Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 91: MEA Market Value (US$ Mn) Analysis, by Type, 2019 to 2023
Table 92: MEA Market Value (US$ Mn) Analysis, by Type, 2024 to 2034
Table 93: MEA Market Value (US$ Mn) Opportunity Analysis, by Type, 2024 to 2034
Table 94: MEA Market Value (US$ Mn) Analysis, by Application, 2019 to 2023
Table 95: MEA Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 96: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Type, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Type, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Type, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Application, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Application, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 20: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 21: North America Market Share Analysis by Country, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by Type, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by Type, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Type, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by Application, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by Application, 2024 to 2034
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 36: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 37: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 40: Latin America Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 41: Latin America Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 42: Latin America Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 43: Latin America Market Share and BPS Analysis by Type, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projections by Type, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Type, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by Application, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by Application, 2024 to 2034
Figure 49: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 50: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 51: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 52: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 53: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 54: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 55: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 56: Western Europe Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 57: Western Europe Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 58: Western Europe Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 59: Western Europe Market Share and BPS Analysis by Type, 2024 & 2034
Figure 60: Western Europe Market Y-o-Y Growth Projections by Type, 2024 to 2034
Figure 61: Western Europe Market Attractiveness Analysis by Type, 2024 to 2034
Figure 62: Western Europe Market Share and BPS Analysis by Application, 2024 & 2034
Figure 63: Western Europe Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 64: Western Europe Market Attractiveness Analysis by Application, 2024 to 2034
Figure 66: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 67: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 68: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 69: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 70: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 71: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 72: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: Eastern Europe Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 74: Eastern Europe Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 75: Eastern Europe Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 76: Eastern Europe Market Share and BPS Analysis by Type, 2024 & 2034
Figure 77: Eastern Europe Market Y-o-Y Growth Projections by Type, 2024 to 2034
Figure 78: Eastern Europe Market Attractiveness Analysis by Type, 2024 to 2034
Figure 79: Eastern Europe Market Share and BPS Analysis by Application, 2024 & 2034
Figure 80: Eastern Europe Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 81: Eastern Europe Market Attractiveness Analysis by Application, 2024 to 2034
Figure 82: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 83: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 84: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 85: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 86: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 87: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 88: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 89: East Asia Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 90: East Asia Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 91: East Asia Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 92: East Asia Market Share and BPS Analysis by Type, 2024 & 2034
Figure 93: East Asia Market Y-o-Y Growth Projections by Type, 2024 to 2034
Figure 94: East Asia Market Attractiveness Analysis by Type, 2024 to 2034
Figure 95: East Asia Market Share and BPS Analysis by Application, 2024 & 2034
Figure 96: East Asia Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 97: East Asia Market Attractiveness Analysis by Application, 2024 to 2034
Figure 98: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 99: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 100: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 101: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 102: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 103: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 104: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 105: South Asia & Pacific Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 106: South Asia & Pacific Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 107: South Asia & Pacific Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 108: South Asia & Pacific Market Share and BPS Analysis by Type, 2024 & 2034
Figure 109: South Asia & Pacific Market Y-o-Y Growth Projections by Type, 2024 to 2034
Figure 110: South Asia & Pacific Market Attractiveness Analysis by Type, 2024 to 2034
Figure 111: South Asia & Pacific Market Share and BPS Analysis by Application, 2024 & 2034
Figure 112: South Asia & Pacific Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 113: South Asia & Pacific Market Attractiveness Analysis by Application, 2024 to 2034
Figure 114: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 115: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 116: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 117: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 118: MEA Market Share Analysis by Country, 2024 & 2034
Figure 119: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 120: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 121: MEA Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 122: MEA Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 123: MEA Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 124: MEA Market Share and BPS Analysis by Type, 2024 & 2034
Figure 125: MEA Market Y-o-Y Growth Projections by Type, 2024 to 2034
Figure 126: MEA Market Attractiveness Analysis by Type, 2024 to 2034
Figure 127: MEA Market Share and BPS Analysis by Application, 2024 & 2034
Figure 128: MEA Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 129: MEA Market Attractiveness Analysis by Application, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the biomarker market in 2024?
The global biomarker market is expected to reach US$ 74.92 billion in 2024.
What is the demand outlook for biomarkers for 2034?
Worldwide sales of biomarkers are approximated to reach US$ 303.98 billion by the end of 2034.
At what CAGR are the sales of biomarkers evaluated to climb?
The market for biomarkers is projected to advance at 15% CAGR from 2024 to 2034.
What is the contribution of North America to global market revenue?
North America is evaluated to account for 35.2% of the global market share by 2034.
At what rate is the demand for biomarkers projected to increase in South Korea?
The market in South Korea is analyzed to accelerate at a CAGR of 17% from 2024 to 2034.
How much share of the global market are safety biomarkers expected to occupy?
Safety biomarkers are forecasted to account for 36.5% share of global market revenue by 2034.
Who are some of the prominent suppliers of biomarkers?
Agilent Technologies, Inc., Qiagen, Abbot Laboratories, F. Hoffman-La Roche Ltd., and Merck KGaA are some of the leading market players.
What are biomarkers in pharma?
Biomarker indicates changes in protein state or expression correlating with the progression or risk of a disease or with susceptibility to disease treatment.
Biomarker Market